Frontera Therapeutics
About:
Frontera Therapeutics is an AAV gene therapy company that focuses on rAAV therapies for the global market.
Website: https://cn.fronteratherapeutics.com
Top Investors: OrbiMed, HongShan, Boyu Capital, Starr Investment Holdings, Creacion Ventures
Description:
Frontera Therapeutics is an AAV gene therapy company with the mission to establish a low-cost and scalable platform, to develop and produce high-quality and affordably priced rAAV therapies for the global market.
Total Funding Amount:
$160M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Bedford, Massachusetts, United States
Founded Date:
2019-09-01
Contact Email:
admin(AT)fronteratherapeutics.com
Founders:
Xinyan Li
Number of Employees:
51-100
Last Funding Date:
2022-06-24
IPO Status:
Private
Industries:
© 2025 bioDAO.ai